Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

SELL
$62.32 - $89.47 $1.79 Million - $2.57 Million
-28,775 Reduced 79.41%
7,460 $640,000
Q3 2022

Nov 03, 2022

BUY
$59.54 - $68.01 $148,850 - $170,025
2,500 Added 7.41%
36,235 $2.24 Million
Q2 2022

Aug 10, 2022

BUY
$57.72 - $65.01 $1.14 Million - $1.28 Million
19,675 Added 139.94%
33,735 $2.09 Million
Q1 2022

May 09, 2022

SELL
$57.92 - $72.58 $995,065 - $1.25 Million
-17,180 Reduced 54.99%
14,060 $836,000
Q4 2021

Feb 08, 2022

SELL
$64.88 - $73.64 $652,368 - $740,450
-10,055 Reduced 24.35%
31,240 $2.27 Million
Q3 2021

Nov 12, 2021

BUY
$67.69 - $73.03 $286,328 - $308,916
4,230 Added 11.41%
41,295 $2.88 Million
Q2 2021

Aug 11, 2021

BUY
$63.47 - $69.35 $668,973 - $730,948
10,540 Added 39.74%
37,065 $2.85 Million
Q1 2021

May 11, 2021

SELL
$60.0 - $68.46 $58,500 - $66,748
-975 Reduced 3.55%
26,525 $1.71 Million
Q4 2020

Feb 09, 2021

BUY
$56.65 - $64.55 $1.56 Million - $1.78 Million
27,500 New
27,500 $1.6 Million
Q3 2020

Nov 12, 2020

SELL
$62.1 - $78.08 $208,097 - $261,646
-3,351 Closed
0 $0
Q2 2020

Aug 07, 2020

SELL
$72.34 - $84.0 $2.54 Million - $2.95 Million
-35,148 Reduced 91.3%
3,351 $258,000
Q1 2020

May 08, 2020

BUY
$62.63 - $80.22 $2.41 Million - $3.09 Million
38,499 New
38,499 $2.88 Million
Q1 2019

May 10, 2019

SELL
$62.53 - $70.05 $575,276 - $644,460
-9,200 Closed
0 $0
Q4 2018

Feb 12, 2019

SELL
$60.54 - $79.0 $982,806 - $1.28 Million
-16,234 Reduced 63.83%
9,200 $575,000
Q3 2018

Nov 13, 2018

BUY
$71.28 - $78.92 $17,107 - $18,940
240 Added 0.95%
25,434 $1.96 Million
Q2 2018

Aug 02, 2018

SELL
$64.88 - $75.68 $34,256 - $39,959
-528 Reduced 2.05%
25,194 $1.79 Million
Q1 2018

May 11, 2018

SELL
$72.84 - $88.8 $89,010 - $108,513
-1,222 Reduced 4.54%
25,722 $1.94 Million
Q4 2017

Feb 09, 2018

SELL
$71.15 - $83.52 $282,394 - $331,490
-3,969 Reduced 12.84%
26,944 $1.93 Million
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $2.23 Million - $2.64 Million
30,913
30,913 $2.51 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Fiera Capital Corp Portfolio

Follow Fiera Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.